SEARCH WITHIN CONTENT
VOLUME 3 , ISSUE 2 ( April-June, 2019 ) > List of Articles
V Krishna Kumar, Alok Kumar Srivastava, Pallavi N Kamble, Pratap Makhija
Keywords : Conjunctivitis, Efficacy, Protocol for a systematic review, Safety,Ayurveda
Citation Information : Kumar VK, Srivastava AK, Kamble PN, Makhija P. Safety and Efficacy of Ayurvedic Interventions in the Management of Conjunctivitis: A Protocol for a Systematic Review. J Res Ayurvedic Sci 2019; 3 (2):64-67.
License: CC BY-NC 4.0
Published Online: 00-06-2019
Copyright Statement: Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.
Background: Conjunctivitis is a common condition of the eye that occurs worldwide and affects all ages and social strata, affecting more than 2% of the population. Conventional treatment has many options for treating the disease. Despite adequate treatment options, patients continue to suffer troublesome symptoms. Complementary and alternative medicine (CAM) therapies may play a significant role here. Systematic reviews on this topic have been published for herbal medicines. Data are available on plenty of studies individually proving efficacy and safety of various Shodhana, Shamana, and Netra Kriyakalpa in conjunctivitis. However, systematic review of Ayurveda interventions for conjunctivitis is unavailable. This study aims at a thorough review of published clinical data of safety and efficacy of Ayurvedic interventions in the management of conjunctivitis. Materials and methods: A systematic review of randomized controlled trials (RCTs), quasi-randomized controlled trials (QRCTs), controlled clinical trials (CCTs), and multiple arms clinical trials on conjunctivitis published till date will be conducted. Studies having patients fulfilling the diagnostic criteria based on the symptomatology of Abhishyanda (HF-1) explained in classic Ayurveda texts and conjunctivitis of all ages and either sex will be included. Studies in which Ayurvedic treatments (Shamana, Shodhana, or/and Netra Kriyakalpa) with any dose, type, schedule, drug, dosage form, and advised Pathayapathya (lifestyle changes) as intervention or control will be selected. The primary outcome will be the response to treatment and onset of serious adverse events. Ethics and dissemination: Formal ethical approval will be obtained. The results will be disseminated through a peer-reviewed publication. Trial registration number: International prospective register for systematic reviews (PROSPERO) number CRD42019129436.